G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)
HC Yang, TH Ma, WY Tjong, A Stern… - Free radical …, 2021 - Taylor & Francis
The COVID-19 pandemic has so far affected more than 45 million people and has caused
over 1 million deaths worldwide. Infection with SARS-CoV-2, the pathogenic agent, which is …
over 1 million deaths worldwide. Infection with SARS-CoV-2, the pathogenic agent, which is …
[HTML][HTML] Hydroxychloroquine in a G6PD-deficient patient with COVID-19 complicated by haemolytic anaemia: culprit or innocent bystander?
F Mastroianni, V Colombie, G Claes… - European journal of …, 2020 - ncbi.nlm.nih.gov
Hydroxychloroquine has been used worldwide as a first-line treatment for patients
hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with …
hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with …
Safety of long-term use of four common conventional disease modifying anti-rheumatic drugs in rheumatoid arthritis
AK Kedia, K Mohansundaram… - Journal of the Royal …, 2021 - journals.sagepub.com
Conventional disease-modifying antirheumatic drugs (DMARDs) have been used in the
management of rheumatoid arthritis for a long time. Whereas methotrexate (MTX) is the …
management of rheumatoid arthritis for a long time. Whereas methotrexate (MTX) is the …